Abstract
Background
Renal ischemia–reperfusion injury (IRI) is a major cause of acute kidney injury. Hydrogen sulfide (H2S) has been known as a novel gaseous signaling molecule.
Aims
The aim of this study was to investigate whether the efficacy of H2S in protecting against renal IRI is through its antioxidative effect.
Method
In this study, rats were randomized into Sham, IR, or sodium hydrosulfide (NaHS, an H2S donor) groups. To establish a model of renal IRI, both renal arteries were occluded for 55 min and then declamped to allow reperfusion for 24 h. Rats in the NaHS group received intraperitoneal injections of 75 μmol/kg NaHS 10 min before the onset of ischemia and immediately after the onset of reperfusion. Sham group underwent laparotomy without cross-clamping of renal pedicles. After reperfusion, plasma and renal tissue samples were collected for functional, histological, and oxidative stress evaluation.
Results
The IR group exhibited significant rise in plasma creatinine, blood urea nitrogen (BUN), renal malondialdehyde (MDA) concentration, and significant reduction of renal superoxide dismutase (SOD) activity. Treatment with NaHS reduced the levels of plasma creatinine, BUN, renal MDA concentration, and increased SOD activity in the kidneys. NaHS improved renal histological changes in comparison to IR group.
Conclusion
Our data demonstrated that H2S can protect against renal IRI and that its therapeutic effects may be mediated by reducing oxidative stress.
This is a preview of subscription content, access via your institution.



References
Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW (2005) Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16:3365–3370
Regner KR, Roman RJ (2012) Role of medullary blood flow in the pathogenesis of renal ischemia-reperfusion injury. Curr Opin Nephrol Hypertens 21:33–38
Tan S, Wang G, Guo Y, Gui D, Wang N (2013) Preventive effects of a natural anti-inflammatory agent, astragaloside IV, on ischemic acute kidney injury in rats. Evid Based Complement Alternat Med 2013:284025
Hunter JP, Hosgood SA, Patel M, Rose R, Read K, Nicholson ML (2012) Effects of hydrogen sulphide in an experimental model of renal ischaemia-reperfusion injury. Br J Surg 99:1665–1671
Hosgood SA, Nicholson ML (2010) Hydrogen sulphide ameliorates ischaemia-reperfusion injury in an experimental model of non-heart-beating donor kidney transplantation. Br J Surg 97:202–209
Williams P, Lopez H, Britt D, Chan C, Ezrin A, Hottendorf R (1997) Characterization of renal ischemia-reperfusion injury in rats. J Pharmacol Toxicol Methods 37:1–7
Kurian GA, Pemaih B (2014) Standardization of in vitro cell-based model for renal ischemia and reperfusion injury. Indian J Pharm Sci 76:348–353
Singh D, Kaur R, Chander V, Chopra K (2006) Antioxidants in the prevention of renal disease. J Med Food 9:443–450
Pham-Huy LA, He H, Pham-Huy C (2008) Free radicals, antioxidants in disease and health. Int J Biomed Sci 4:89–96
Yun Y, Duan WG, Chen P, Wu HX, Shen ZQ, Qian ZY et al (2009) Ischemic postconditioning modified renal oxidative stress and lipid peroxidation caused by ischemic reperfusion injury in rats. Transplant Proc 41:3597–3602
Davies KJ (1987) Protein damage and degradation by oxygen radicals. I. general aspects. J Biol Chem 262:9895–9901
Ivanov AV, Bartosch B, Smirnova OA, Isaguliants MG, Kochetkov SN (2013) HCV and oxidative stress in the liver. Viruses 5:439–469
Ferrari R, Ceconi C, Curello S, Cargnoni A, Pasini E, De Giuli F et al (1991) Role of oxygen free radicals in ischemic and reperfused myocardium. Am J Clin Nutr 53:215S–222S
Paller MS, Hoidal JR, Ferris TF (1984) Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest 74:1156–1164
Wallace JL, Blackler RW, Chan MV, Da Silva GJ, Elsheikh W, Flannigan KL et al (2015) Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics. Antioxid Redox Signal 22(5):398–410
King AL, Lefer DJ (2011) Cytoprotective actions of hydrogen sulfide in ischaemia-reperfusion injury. Exp Physiol 96:840–846
Bracht H, Scheuerle A, Groger M, Hauser B, Matallo J, McCook O et al (2012) Effects of intravenous sulfide during resuscitated porcine hemorrhagic shock*. Crit Care Med 40:2157–2167
Xue H, Yuan P, Ni J, Li C, Shao D, Liu J et al (2013) H(2)S inhibits hyperglycemia-induced intrarenal renin-angiotensin system activation via attenuation of reactive oxygen species generation. PLoS ONE 8:e74366
Esterbauer H, Schaur RJ, Zollner H (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11:81–128
Paoletti F, Mocali A (1990) Determination of superoxide dismutase activity by purely chemical system based on NAD (P) H Oxidation. Methods Enzymol 186:209–220
Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L et al (2007) Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104:15560–15565
Hunter J, Hosgood S, Patel M, Rose R, Read K, Nicholson M (2012) Effects of hydrogen sulphide in an experimental model of renal ischaemia–reperfusion injury. Br J Surg 99:1665–1671
Ekici F, Karson A, Dillioglugil MO, Gurol G, Kir HM, Ates N (2013) The effects of vagal nerve stimulation in focal cerebral ischemia and reperfusion model. Turk Neurosurg 23:451–457
Bos EM, Wang R, Snijder PM, Boersema M, Damman J, Fu M et al (2013) Cystathionine gamma-lyase protects against renal ischemia/reperfusion by modulating oxidative stress. J Am Soc Nephrol 24:759–770
Bos EM, Leuvenink HG, Snijder PM, Kloosterhuis NJ, Hillebrands JL, Leemans JC et al (2009) Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury. J Am Soc Nephrol 20:1901–1905
Tripatara P, Patel NS, Brancaleone V, Renshaw D, Rocha J, Sepodes B et al (2009) Characterisation of cystathionine gamma-lyase/hydrogen sulphide pathway in ischaemia/reperfusion injury of the mouse kidney: an in vivo study. Eur J Pharmacol 606:205–209
Kim J, Jang HS, Park KM (2010) Reactive oxygen species generated by renal ischemia and reperfusion trigger protection against subsequent renal ischemia and reperfusion injury in mice. Am J Physiol Renal Physiol 298:F158–F166
Xu Z, Prathapasinghe G, Wu N, Hwang SY, Siow YL (2009) O K. Ischemia-reperfusion reduces cystathionine-beta-synthase-mediated hydrogen sulfide generation in the kidney. Am J Physiol Renal Physiol 297:F27–F35
Liu H, Bai XB, Shi S, Cao YX (2009) Hydrogen sulfide protects from intestinal ischaemia–reperfusion injury in rats. J Pharm Pharmacol 61:207–212
Zhou X, Feng Y, Zhan Z, Chen J (2014) Hydrogen sulfide alleviates diabetic nephropathy in a streptozotocin-induced diabetic rat model. J Biol Chem 289:28827–28834
Liu H, Bai XB, Shi S, Cao YX (2009) Hydrogen sulfide protects from intestinal ischaemia-reperfusion injury in rats. J Pharm Pharmacol 61:207–212
Cheng P, Wang F, Chen K, Shen M, Dai W, Xu L et al (2014) Hydrogen sulfide ameliorates ischemia/reperfusion-induced hepatitis by inhibiting apoptosis and autophagy pathways. Mediators Inflamm 2014:935251
Webster KA (2012) Mitochondrial membrane permeabilization and cell death during myocardial infarction: roles of calcium and reactive oxygen species. Future Cardiol 8:863–884
Wang JF, Li Y, Song JN, Pang HG (2014) Role of hydrogen sulfide in secondary neuronal injury. Neurochem Int 64:37–47
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
None.
Rights and permissions
About this article
Cite this article
Azizi, F., Seifi, B., Kadkhodaee, M. et al. Administration of hydrogen sulfide protects ischemia reperfusion-induced acute kidney injury by reducing the oxidative stress. Ir J Med Sci 185, 649–654 (2016). https://doi.org/10.1007/s11845-015-1328-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-015-1328-z
Keywords
- Renal
- Ischemia
- Reperfusion
- Hydrogen sulfide